Dr. Edith Gorecki is a Medical Affairs Executive in the pharmaceutical industry specializing in clinical research and regulatory affairs. She has expertise across multiple therapeutic areas but her current sub-specialization is within neurological disease. She has been instrumental in collaborating with regulatory bodies (FDA, Health Canada, EMA, SWISSMEDIC, TGA) to receive indication approval for investigational molecules. Edith is an expert in creating clinical programs incorporating novel endpoints which can lead to diverse therapeutic options in the future.